|
⚲
|
| Keyboard |
| Sagimet Biosciences Inc | |
|---|---|
| Ticker | SGMT |
| CIK # | 0001400118 |
| CUSIP | 786700104 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 155 Bovet Rd, Suite 303, San Mateo, CA 94402 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Sagimet Biosciences Inc | 2021-01-05 | 69.0 M | Exemption: 506(b) · Remaining: $11,000,000 · Duration: One year or less · Revenue: Decline to Disclose |
| 3-V Biosciences Inc | 2019-02-25 | 35.2 M | Exemption: 506(b) · Remaining: $6,992,524 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001400118] | 10-K | |
| [0001400118] | 10-Q | |
| [0001400118] | 3 | |
| [0001400118] | 4 | |
| [0001400118] | 8-K | |
| [0001400118] | D | |
| [0001400118] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Martins Eduardo Bruno
Series A Common Stock
|
2026-02-19 | Grant | 44,000 | $0.00 | |
|
Rozek Elizabeth
Series A Common Stock
|
2026-02-19 | Grant | 44,000 | $0.00 | |
|
Chauche Thierry
Stock Option (Right to Buy) · derivative
|
2026-02-19 | Grant | 88,000 | $0.00 | |
|
Happel David
Stock Option (Right to Buy) · derivative
|
2026-02-19 | Grant | 256,000 | $0.00 | |
|
Martins Eduardo Bruno
Stock Option (Right to Buy) · derivative
|
2026-02-19 | Grant | 88,000 | $0.00 | |
|
Rozek Elizabeth
Stock Option (Right to Buy) · derivative
|
2026-02-19 | Grant | 88,000 | $0.00 | |
|
Chauche Thierry
Series A Common Stock
|
2026-02-19 | Grant | 44,000 | $0.00 | |
|
Happel David
Series A Common Stock
|
2026-02-19 | Grant | 128,000 | $0.00 | |
|
Chauche Thierry
Series A Common Stock
|
2026-02-10 | Sell | 1,312 | $5.36 | 7,032 |
|
Rozek Elizabeth
Series A Common Stock
|
2026-02-10 | Sell | 2,622 | $5.36 | 14,054 |
|
Happel David
Series A Common Stock
|
2026-02-10 | Sell | 12,101 | $5.36 | 64,861 |
|
Martins Eduardo Bruno
Series A Common Stock
|
2026-02-10 | Sell | 3,640 | $5.36 | 19,510 |
|
Kemble George
Series A Common Stock
|
2025-11-20 | Sell | 37,688 | $7.69 | 289,821 |
|
Rozek Elizabeth
Series A Common Stock
|
2025-11-04 | Grant | 9,855 | $0.00 | |
|
Rozek Elizabeth
Stock Option (Right to Buy) · derivative
|
2025-11-04 | Grant | 13,367 | $0.00 | |
|
Rozek Elizabeth
Series A Common Stock
|
2025-07-21 | Sell | 10,780 | $9.13 | 98,421 |
|
Martins Eduardo Bruno
Series A Common Stock
|
2025-07-21 | Sell | 8,277 | $9.13 | 75,569 |
|
Happel David
Series A Common Stock
|
2025-07-21 | Sell | 65,478 | $9.13 | 597,814 |
|
Walbert Timothy P
Stock Option (Right to Buy) · derivative
|
2025-06-09 | Grant | 32,250 | $0.00 | |
|
Grammer Elizabeth A
Stock Option (Right to Buy) · derivative
|
2025-06-09 | Grant | 32,250 | $0.00 | |
| showing 20 of 170 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 88 | 13,619,525 |
| 2025-12-31 | 86 | 14,668,031 |
| 2025-09-30 | 72 | 12,958,733 |
| 2025-06-30 | 68 | 12,187,989 |
| 2025-03-31 | 71 | 13,806,304 |
| 2024-12-31 | 67 | 17,668,354 |
| 2024-09-30 | 64 | 19,809,168 |
| 2024-06-30 | 83 | 20,748,113 |
| 2024-03-31 | 82 | 23,861,465 |
| 2023-12-31 | 52 | 14,460,490 |
| 2023-09-30 | 49 | 15,567,815 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Abacus Planning Group Inc | [2026-06-30] | SOLE | 0 | 18,064 |
| Physician Wealth Advisors Inc | [2026-06-30] | SOLE | 0 | 317 |
| FNY Investment Advisers LLC | [2026-06-30] | SOLE | 109,250 | 109 | Prev | Page 1 | Next |